Topiramate IR Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Topiramate IR Pellets Manufacturer in India

Pharmaceutical-Grade Topiramate IR Pellets for Immediate-Release Oral Formulations

Topiramate IR Pellets are multiparticulate pharmaceutical formulations designed for immediate-release oral dosage applications. Topiramate is identified by CAS Number 97240-79-4, molecular formula C₁₂H₂₁NO₈S, and molecular weight 339.36 g/mol. These chemical identifiers are confirmed by PubChem.

The SDP pellet product portfolio lists Topiramate IR Pellets at 7.50% strength, providing a defined active-loading option for pharmaceutical formulation development.

The immediate-release pellet format provides a multiparticulate platform designed for release of the active ingredient according to the applicable formulation specification. Pellet composition, active loading, particle characteristics and manufacturing parameters influence the final release performance.

Key Features

  • Topiramate immediate-release pharmaceutical pellets
  • 7.50% active ingredient strength
  • Pharmaceutical-grade multiparticulate formulation
  • Immediate-release formulation platform
  • Suitable for oral dosage-form development
  • Suitable for capsule-filling applications
  • Defined active ingredient loading
  • Product-specific quality parameters
  • Formulation flexibility
  • Suitable for bulk pharmaceutical requirements

Product Information

Topiramate has the molecular formula C₁₂H₂₁NO₈S and molecular weight 339.36 g/mol. PubChem identifies 97240-79-4 as the CAS Number for Topiramate.

Topiramate is a stereochemically defined pharmaceutical ingredient. Therefore, the identity and stereochemical requirements of the raw material should be controlled according to the applicable approved specification.

For Topiramate IR Pellets, the 7.50% value represents active ingredient loading in the finished pellet formulation and should not be confused with the purity assay of the Topiramate raw material.

Available Strength

Topiramate IR Pellets — 7.50%

The 7.50% strength is specifically listed for Topiramate IR Pellets in the SDP pellet product catalogue.

Applications

Topiramate IR Pellets can be considered for:

  • Immediate-release oral formulation development
  • Multiparticulate pharmaceutical formulations
  • Capsule-filling applications
  • Oral dosage-form development
  • Pharmaceutical formulation development
  • Commercial pharmaceutical manufacturing

Why Topiramate IR Pellets from Swapnroop?

  • Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
  • 7.50% Strength: Defined active-loading option for formulation development.
  • Immediate-Release Format: Designed for immediate-release multiparticulate applications.
  • Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
  • Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
  • Capsule-Filling Applications: Suitable for multiparticulate capsule formulation approaches.
  • Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Topiramate IR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 97.0% – 103.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 0.5%
Get Bulk Quote via WhatsApp